Mega-Merger Could Usher In New Era Of Consolidation

Given the looming patent cliff facing drug manufacturers and the lack of new products coming out of R&D to replace lost sales, it's hardly surprising that murmurings of industry consolidation are swirling

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet